A decrease in the severity of chronic colitis was also observed with intravenous administration of the drug at a dose of 1 mg/kg and was demonstrated to be comparable to a similar dose of antibodies against TNF-α (0.03 mg/mouse) [46,47]. This evidence concerns the gene TNF and Chronic colitis.